DESMOPRESSIN ACETATE
LOE ApproachingNDAORALTABLET
Approved
May 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
DESMOPRESSIN ACETATE by Ferring Pharmaceuticals is 12. Approved for nephrogenic diabetes insipidus, there is evidence of an abnormal molecular form of factor viii antigen, severe von willebrand’s disease (type i) and 2 more indications. First approved in 2008.
Drug data last refreshed 11h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Desmopressin acetate is a synthetic vasopressin analog administered orally as a tablet that increases factor VIII activity and reduces urine production by stimulating V2 receptors in the kidney. It treats central diabetes insipidus, hemophilia A, and von Willebrand's disease Type I by enhancing water reabsorption and hemostatic function. The drug has a selective antidiuretic profile with minimal vasopressor effects compared to natural vasopressin.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), indicating transition planning and potential team restructuring ahead.
Mechanism of Action
12.1 Mechanism of Action Desmopressin acetate increases plasma levels of factor VIII activity in patients with hemophilia and von Willebrand’s disease Type I. The antidiuretic effects of desmopressin acetate are mediated by stimulation of vasopressin 2 (V2) receptors, thereby increasing water…
Worked on DESMOPRESSIN ACETATE at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.